The latest board meeting for Sangamo Therapeutics Inc took place on 20 Mar 2025, for the purpose of Sangamo Therapeutics Inc Annual Report for 2024See details
Sangamo Therapeutics Inc has a share price target of US$ 5, revenue growth forecast of -50.4%, and profit growth estimate of -2.4% for FY25, based on top 8 analyst calls.